Abstract:Ferroptosis is a novel form of non-apoptotic regulated cell death (RCD), with distinct characteristics and functions in physical conditions and multiple diseases such as cancers. Unlike apoptosis and autophagy, this new RCD is an iron-dependent cell death with features of lethal accumulation of reactive oxygen species (ROS) and over production of lipid peroxidation. Excessive iron from aberrant iron metabolisms or the maladjustment of the two main redox systems thiols and lipid peroxidation role as the major causes of ROS generation, and the redox-acrive ferrous (intracellular labile iron) is a crucial factor for the lipid peroxidation. Regulation of ferrroptosis also involves different pathways such as mevalonate pathway, P53 pathway and p62-Keap1-Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway. Ferroptosis roles as a double-edged sword either suppressing or promoting tumor progression with the release of multiple signaling molecules in the tumor microenvironment. Emerging evidence suggests ferroptosis as a potential target for cancer therapy and ferroptosis inducers including small molecules and nanomaterials have been developed. The application of ferroptosis inducers also relates to overcoming drug resistance and preventing tumor metastasis, and may become a promising strategy combined with other anti-cancer therapies. Here, we summarize the ferroptosis characters from its underlying basis and role in cancer, followed by its possible applications in cancer therapies and challenges maintained.

p53: A double-edged sword in tumor ferroptosis

Ferroptosis and the bidirectional regulatory factor p53

The Regulation of Ferroptosis by Tumor Suppressor P53 and Its Pathway

p53 in ferroptosis regulation: the new weapon for the old guardian

p53 tumor suppressor and iron homeostasis.

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy

Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine

The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity

P53 Together with Ferroptosis: a Promising Strategy Leaving Cancer Cells Without Escape.

Ferroptosis as a p53-mediated activity during tumour suppression

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis As a Mechanism to Mediate P53 Function in Tumor Radiosensitivity

Ferroptosis: A double-edged sword

P53 Regulation upon Lipid Peroxidation and Ferroptosis for Intervention against Atherogenesis

Ferroptosis and its emerging role in tumor

Ferroptosis in life: To be or not to be

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

Ferroptosis in liver diseases: Fundamental mechanism and clinical implications

Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53

Ferroptosis as a potential target for cancer therapy

Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters